Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Capsule Innovations: Speeding Up Drug Development

September 03, 2020

Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.

Manufacturing Drug–Device Combination Products

September 03, 2020

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.

Making the Ideal Dosage Form

September 02, 2020

End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.

Solid-Dose Continuous Manufacturing Presses On

September 02, 2020

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.

Catalent to Manufacture Drug Substance for AstraZeneca’s COVID-19 Vaccine Candidate

August 24, 2020

Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.

EC Reaches Agreement with AstraZeneca on Purchase of COVID-19 Vaccine

August 20, 2020

EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.

CARBOGEN AMCIS Invests Heavily in Switzerland and France

August 20, 2020

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

Novavax Signs Term Sheet with UK Gov for COVID-19 Vaccine Doses

August 20, 2020

Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial.

Expanding Options for Vaccine Packaging

August 19, 2020

Plastic primary packaging could help prevent supply chain shortages associated with high demand for COVID-19 vaccines.

Novavax and Fujifilm Diosynth Biotechnologies Begin Manufacturing of COVID-19 Vaccine Candidate

July 23, 2020

Fujifilm Diosynth Biotechnologies’ North Carolina site will be used to manufacture Novavax’ NVX‑CoV2373 vaccine candidate for a Phase III clinical trial.